KMT2A and precursor B-cell acute lymphoblastic leukemia: Altogether, these observations suggest that KMT2A fusions, particularly KMT2A-AFF1, have the capacity to choose and activate either the IRX or HOXA program and eventually cause the different developmental phenotypes of B-ALL.